Pfizer (NYSE:PFE) CEO Albert Bourla is expected to meet with activist investor Starboard Value next week after the activist accumulated a $1 billion stake in the pharma giant.

Pfizer’s Albert Bourla has become a fixture among Fortune ... The products born from research spawned with public money? As NYAS CEO Nicholas Dirks, a former chancellor of Berkeley, said last ...

In a year in which he faced down a challenge from an activist investor, Pfizer CEO Albert Bourla, Ph.D., received a 14% total pay increase, according (PDF) to a securities filing. The CEO's ...

When a novel coronavirus struck in early 2020, Pfizer’sPFE1.22%increase; green up pointing triangle chief executive, Dr. Albert Bourla ... The Greek-born CEO’s bold bet paid off.

Albert Bourla, who four years ago led Pfizer through its scientific and financial ... CNN named Bourla CEO of the year in 2021, beating out Alphabet’s Sundar Pichai and billionaire Elon Musk.

Pfizer reaffirmed $10–$15 billion for business ... Haider pointed out that investors paid close attention to CEO Albert Bourla’s comments on tariffs. Bourla said the government’s primary ...

Like his Big Pharma peers, Pfizer (PFE) CEO Albert Bourla is waiting for the US government to finalize its decision on whether to place a 25% tariff on pharmaceutical imports. To be sure ...

Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing and ...

Super pleased to have Albert Bourla, CEO of Pfizer, to join us here and sit down and have a conversation. Extremely timely, so many things to cover. I think your team had wanted you to be able to ...

A 2023 quote from Pfizer CEO Albert Bourla describing the COVID-19 pandemic as a “rehearsal” has been taken out of context and misrepresented on social media as an admission the pandemic was ...

In today’s CEO Daily: Diane Brady talks to Pfizer CEO Albert Bourla about defending science amid a backdrop of political threats. The big story: Trump’s tariff regime is open to compromises.